JP2005060406A5 - - Google Patents

Download PDF

Info

Publication number
JP2005060406A5
JP2005060406A5 JP2004293637A JP2004293637A JP2005060406A5 JP 2005060406 A5 JP2005060406 A5 JP 2005060406A5 JP 2004293637 A JP2004293637 A JP 2004293637A JP 2004293637 A JP2004293637 A JP 2004293637A JP 2005060406 A5 JP2005060406 A5 JP 2005060406A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004293637A
Other languages
Japanese (ja)
Other versions
JP2005060406A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005060406A publication Critical patent/JP2005060406A/ja
Publication of JP2005060406A5 publication Critical patent/JP2005060406A5/ja
Pending legal-status Critical Current

Links

JP2004293637A 1993-04-27 2004-10-06 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器 Pending JP2005060406A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5716693A 1993-04-27 1993-04-27
US22927594A 1994-04-14 1994-04-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52461494A Division JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Publications (2)

Publication Number Publication Date
JP2005060406A JP2005060406A (ja) 2005-03-10
JP2005060406A5 true JP2005060406A5 (enExample) 2005-09-08

Family

ID=26736147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP52461494A Expired - Lifetime JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器
JP2004293637A Pending JP2005060406A (ja) 1993-04-27 2004-10-06 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52461494A Expired - Lifetime JP3795914B2 (ja) 1993-04-27 1994-04-28 ワクチン用免疫原性lhrhペプチド構築体および合成普遍免疫刺激器

Country Status (11)

Country Link
EP (1) EP0708656B1 (enExample)
JP (2) JP3795914B2 (enExample)
AT (1) ATE221387T1 (enExample)
AU (1) AU687805B2 (enExample)
CA (1) CA2161445C (enExample)
DE (1) DE69431114T2 (enExample)
DK (1) DK0708656T3 (enExample)
ES (1) ES2180576T3 (enExample)
FI (1) FI955101A7 (enExample)
NO (1) NO316121B1 (enExample)
WO (1) WO1994025060A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
EP0687182B1 (en) * 1993-02-26 2003-08-06 The Scripps Research Institute Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
AU2195395A (en) * 1994-03-28 1995-10-17 United Biomedical Inc. Synthetic peptide based immunogens for the treatment of allergy
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja) 1995-06-06 2007-04-25 アバント イミュノーセラピューティクス,インコーポレイテッド Hdlコレステロールレベルを増大する方法
US5843462A (en) 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
CN1174998C (zh) 1996-03-01 2004-11-10 诺瓦提斯公司 用于预防和治疗过敏的肽免疫原
AU722327B2 (en) 1996-04-19 2000-07-27 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
US6942861B2 (en) * 1996-04-19 2005-09-13 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
US6846808B1 (en) 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6309646B1 (en) 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
WO1997049425A1 (en) * 1996-06-25 1997-12-31 Stichting Instituut Voor Dierhouderij En Diergezondheid Vaccine comprising antigens bound to carriers through labile bonds
DE69832706T2 (de) * 1997-08-05 2006-08-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Immunschützendes influenzaantigen und dessen verwendung zur impfung
WO1999030736A2 (en) 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6025468A (en) * 1998-06-20 2000-02-15 United Biomedical, Inc. Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
WO2000032626A1 (en) * 1998-11-25 2000-06-08 Regents Of The University Of Minnesota Methods of using epitope peptides of human pathogens
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
US6783761B2 (en) 2000-05-05 2004-08-31 Aphton Corporation Chimeric peptide immunogens
US6780969B2 (en) * 2000-12-22 2004-08-24 United Biomedical, Inc. Synthetic peptide composition as immunogens for prevention of urinary tract infection
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US8088388B2 (en) * 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
MXPA04010255A (es) * 2002-04-19 2008-03-04 Univ Toronto Metodos inmunologicos y composiciones para el tratamiento de la enfermedad de alzheimier.
EP1624884A4 (en) 2003-04-22 2009-08-05 Ipsen Pharma SOMATOSTATIN VECTORS
CN101084239A (zh) * 2004-09-10 2007-12-05 昆士兰医学研究所理事会(Qimr) 截短的lhrh制剂
AU2006247188A1 (en) 2005-05-18 2006-11-23 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against chlamydia infection
RU2007143992A (ru) * 2005-06-01 2009-07-20 Пфайзер Продактс Инк. (Us) Вакцинные композиции и способы лечения недержания мочи
JP2010538981A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 単独でまたはペプチドGly−Arg−Gly−Asp−Asn−Pro−OHと組み合わせて用いる、治療剤としてのペプチドHis−Ser−Leu−Gly−Lys−Trp−Leu−Gly−His−Pro−Asp−Lys−Pheの使用
JP4535174B2 (ja) 2008-07-11 2010-09-01 トヨタ自動車株式会社 車両の制御装置および制御方法
MX382968B (es) 2012-11-16 2025-03-12 United Biomedical Inc Vacuna de emergencia basada en péptidos sintéticos contra la fiebre aftosa.
WO2016014071A1 (en) * 2014-07-25 2016-01-28 United Biomedical, Inc Immunogenic lhrh composition and use thereof in pigs
WO2018178352A1 (en) * 2017-03-30 2018-10-04 Progastrine Et Cancers S.À R.L. Compositions and methods for detecting prostate cancer
SG11202106485YA (en) * 2018-12-19 2021-07-29 United Biomedical Inc Artificial promiscuous t helper cell epitopes as immune stimulators for synthetic peptide immunogens
TW202144387A (zh) * 2020-02-11 2021-12-01 美商聯合生物醫學公司 針對胰島澱粉樣多肽(iapp)的胜肽免疫原及其預防和治療與聚集iapp相關疾病的製劑

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613586A (en) * 1984-04-19 1986-09-23 Board Of Trustees Of The Leland Stanford Junior University Gastrin releasing peptide-like peptides
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
AU2012488A (en) * 1987-07-31 1989-02-02 Syntex (U.S.A.) Inc. Combination therapy with lhrh antagonist analogs and 19nor progestational steroids
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
US5500366A (en) * 1990-09-18 1996-03-19 Biotech Australia Pty. Ltd. Polynucleotide encoding T-cell epitopes of the protein TraT
HUT67159A (en) * 1991-05-13 1995-02-28 Univ California Liposomal polysaccharide vaccines
JP3738395B2 (ja) * 1991-08-26 2006-01-25 エピミューン,インコーポレイティド Hla−制限型b型肝炎ウィルスのctlエピトープ

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2022C549I2 (enExample)
BE2021C001I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2018C045I2 (enExample)
BE2020C525I2 (enExample)
BE2017C063I2 (enExample)
BE2017C027I2 (enExample)
BE2017C023I2 (enExample)
BE2017C002I2 (enExample)
BE2016C067I2 (enExample)
BE2016C014I2 (enExample)
BE2015C041I2 (enExample)
BE2015C038I2 (enExample)
BE2015C066I2 (enExample)
BE2012C025I2 (enExample)
DE602005006830D1 (enExample)
JP2005060406A5 (enExample)
BE2015C033I2 (enExample)